Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation.

Alashger BK, Alnoiser SN, Kaltham AH, Ahmed AR, Elkattawy HA

Open source

DOI
10.1016/j.msard.2026.107893
Published
2026 Aug 29
Container
Multiple sclerosis and related disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107893,
  title = {Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation.},
  author = {Alashger BK and Alnoiser SN and Kaltham AH and Ahmed AR and Elkattawy HA},
  year = {2026},
  journal = {Multiple sclerosis and related disorders},
  doi = {10.1016/j.msard.2026.107893},
  url = {https://doi.org/10.1016/j.msard.2026.107893}
}

RIS

TY  - JOUR
TI  - Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation.
AU  - Alashger BK
AU  - Alnoiser SN
AU  - Kaltham AH
AU  - Ahmed AR
AU  - Elkattawy HA
PY  - 2026
JO  - Multiple sclerosis and related disorders
DO  - 10.1016/j.msard.2026.107893
UR  - https://doi.org/10.1016/j.msard.2026.107893
ER  - 

APA

BK, A., SN, A., AH, K., AR, A., & HA, E. (2026). Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2026.107893

Source records